Filion KB, Azoulay L, Platt RW, Dahl M, Dormuth CR, Clemens KK, Hu N, Paterson JM, Targownik L, Turin TC, et al
A handful of recent observational studies have linked GLP-1s to lower cancer risks and/or improved outcomes in cancer survivors, but prospective datathe gold standard in clinical researchis lacking
Community sources describe deeper sleep becoming the norm rather than an occasional good night, with recovery from training sessions feeling noticeably faster
Orforglipron vs tirzepatide Once-daily pill vs weekly injection Expected 14-15% vs 20.9% weight loss Anticipated insurance coverage comparison Foundayo vs Wegovy Oral Options Comparing Eli Lilly's new oral GLP-1 with Novo Nordisk's established option